YTHDC2 and cardiac hypertrophy: Ythdc2 interacts with SLC7A11 mRNA, facilitating its degradation and resulting in decreased GSH levels, thereby modulating ferroptosis in cardiomyocytes and influencing cardiac hypertrophy.